Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2016 - 2021)

Historic Change in Acquisitions & Divestments for Anika Therapeutics (ANIK) over the last 7 years, with Q1 2021 value amounting to $2.5 million.

  • Anika Therapeutics' Change in Acquisitions & Divestments fell 8331.55% to $2.5 million in Q1 2021 from the same period last year, while for Dec 2021 it was $2.5 million, marking a year-over-year decrease of 9444.22%. This contributed to the annual value of $2.5 million for FY2021, which is 9444.22% down from last year.
  • As of Q1 2021, Anika Therapeutics' Change in Acquisitions & Divestments stood at $2.5 million, which was down 8331.55% from $18.0 million recorded in Q4 2020.
  • Anika Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $58.8 million for Q4 2019, and its period low was $2.5 million during Q1 2021.
  • Its 5-year average for Change in Acquisitions & Divestments is $16.6 million, with a median of $11.5 million in 2018.
  • Per our database at Business Quant, Anika Therapeutics' Change in Acquisitions & Divestments surged by 41106.09% in 2019 and then plummeted by 8331.55% in 2021.
  • Quarter analysis of 5 years shows Anika Therapeutics' Change in Acquisitions & Divestments stood at $10.2 million in 2017, then increased by 12.2% to $11.5 million in 2018, then soared by 411.06% to $58.8 million in 2019, then plummeted by 69.37% to $18.0 million in 2020, then tumbled by 86.11% to $2.5 million in 2021.
  • Its Change in Acquisitions & Divestments stands at $2.5 million for Q1 2021, versus $18.0 million for Q4 2020 and $7.0 million for Q3 2020.